The Federal Trade Commission (FTC), the Department of Justice’s Antitrust Division, and the U.S. Department of Health and Human Services jointly announced a cross-government inquiry into the impact of private equity investment and other forms of “corporate greed” in the health care sector. As part of the announcement of this effort, the agencies produced a public workshop, hosted by the FTC and entitled, “Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care.” Before the workshop, the agencies issued a request for information (RFI) seeking public comment on transactions in the health care sector involving private equity firms and other private corporate entities. Responses to the RFI are due by May 6, 2024.

Members of our Antitrust & Competition Team and the Life Sciences Health Industry Group have come together to provide an alert that will give you all that you need to know about this new effort by the enforcement agencies. Reed Smith will continue to follow developments on this inquiry. If you have any questions, please do not hesitate to reach out to any of the authors of the alert.